cerrar
Tagged with BIO

Johnsee Lee – Chairman, Taiwan Bio Industry Organization
Johnsee Lee, chairman of Taiwan Bio Industry Organization, gives an update on the major developments of the country’s biotech environment over…

BIO 2019: Hong Kong Biotech IPOs Soaring in Line with China…
With Hong Kong now established as the world’s second largest funding hub for biotech, at this week’s BIO 2019 conference in Philadelphia, the…

Hong Kong Now the World’s Second Largest Funding Hub for…
Hong Kong is now the world's second largest funding hub for biotech according to Hong Kong Chief Executive Carrie Lam. During her speech at the 2nd…

3D Bioprinting: Swedish Firm Cellink at the Forefront
Gothenburg-headquartered Cellink has gone from a start-up to one of the world’s leading 3D bioprinting firms in just four years; firmly positioning…

Carsten Lu – CEO, Adlai Nortye, China
Carsten Lu of Chinese biotech Adlai Nortye outlines his strategy for navigating a crowded immuno-oncology field in China, his partnership strategy,…

Wafik Bardissi – Chairman and CEO, Minapharm, Egypt
Dr Wafik Bardissi, chairman and CEO of Minapharm, the only company to offer biosimilars in Egypt, highlights how the company has successfully…

NEW Korea Pharma Report Out Now
One of the indisputable economic success stories of the last half-century, South Korea now stands as the world’s 11th largest economy, with a…

TJ Deng – GM China & Ian Wisenberg – CFO,…
TJ Deng, GM China and BioDuro Discovery; and Ian Wisenberg, CFO of BioDuro, share the strategic rationale behind Advent International’s 2019…

Chengbin Wu – CEO, EpimAb Biotherapeutics, China
Dr Chengbin Wu, founder and CEO of EpimAb Biotherapeutics, introduces their exciting and proprietary bispecific antibody-generating platform,…

Frédéric Cren – Chairman, CEO & Co-Founder,…
Inventiva is a French clinical-stage biotech company focused on developing oral small molecule epigenetic modulators in therapeutic areas with high…

Jean-Jacques Garaud – CEO, Inotrem, France
Inotrem is a French biotech company developing a novel approach to target inflammatory diseases based on the TREM-1 pathway. Its CEO, Dr Jean-Jacques…

Marc Comas – Managing Director, Accord Healthcare Iberia
Marc Comas, managing director of Accord Healthcare Iberia, highlights the footprint of the company as the leading generics and biosimilars player in…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here